ENVB Enveric Biosciences Inc: Net earnings per share for the last 12 months

Official company branding of Enveric Biosciences Inc (ENVB)

Efficient cross-border logistics of biological raw materials provide Enveric Biosciences (ENVB) with high margins and protection against customs risks. The TTM YoY earnings per share trend demonstrates market equilibrium, with the value fixed at 87.10. The current share price already prices in early R&D costs, while future growth depends on the success of psychedelic trials and the patent protection of new molecules.

Enveric Biosciences Inc (ENVB): Earnings per share for the last twelve months from 02/11/2024 to 11/16/2026

Enveric Biosciences Inc - analytical breakdowns and key metrics (ENVB)

- company stock capitalization data:
Initial company analysis:Enveric Biosciences, Inc. ENVB
Flagship merchandise of Enveric Biosciences, Inc.

Stress testing assets requires an analysis of actual profit dynamics to assess capital stability. Enveric Biosciences (ENVB) is aggressively developing proprietary psychedelic molecules amidst fierce industry competition. The EPS YoY (TTM) percentage growth history measures the annual change in net income per share, reflecting the business's scaling pace. This momentum demonstrates the efficiency of R&D investments relative to market risks. High volatility in this metric confirms the speculative nature of the startup.

Competitor analysis for Enveric Biosciences

Earnings per share for the trailing year INDV (Indivior plc)|Collegium Corp (COLL) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Cronos|CGC (Canopy Growth Corp.) - Net earnings per share (EPS TTM)|HITI: Earnings per share for the trailing year|Earnings per share for the last twelve months Aurora Cannabis, Inc. (ACB)|Net earnings per share for the last 12 months Achieve Life Sciences, Inc. ACHV|skyebioscience.com - Net earnings per share for the last 12 months|Anebulo (ANEB) - Net earnings per one share for the last twelve months|Canndoc - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NTRB (nutriband.com)|Nasus Pharma Ltd (NSRX) - Earnings per share for the last twelve months|India Globalization Capital - Earnings per share for the trailing year|Earnings per share for the last twelve months MIRA Pharma|FLGC: Earnings per share for the trailing year|Earnings per share for the last twelve months IMC (IMCC)|ADIL: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) ARTL (Artelo)|Earnings per share for the trailing year ENSC|Titan Pharmaceuticals - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Greenlane Holdings|inmedpharma.com (INM) - Earnings per share for the last twelve months|Earnings per share for the last 12 months AKAN|BGXX (Bright Green Corp.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Hempacco Co., Inc. HPCO